Italia markets open in 2 hours 32 minutes

Arch Therapeutics, Inc. (0HHJ.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a portafoglio
0,1290+0,1290 (+514,73%)
Alla chiusura: 5:01PM BST
Schermo intero
Chiusura precedente0,0706
Aperto0,1290
Denaro0,0000 x N/D
Lettera0,0000 x N/D
Min-Max giorno0,1290 - 0,1290
Intervallo di 52 settimane0,1290 - 0,1290
Volume800
Media VolumeN/D
CapitalizzazioneN/D
Beta (5 anni mensile)-0,71
Rapporto PE (ttm)N/D
EPS (ttm)-0,0280
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Arch Therapeutics to Present AC5 Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC) Fall

    AC5® Advanced Wound System Selected for Innovation SpotlightFRAMINGHAM, Mass., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical devices, today announced that it will be presenting at the 2021 Symposium on Advanced Wound Care (SAWC) Fall. The event is being held at Caesars Palace, Las Vegas, Nevada from October 29-31, 2021. The Company will be discussing AC5® Advanced Wou

  • GlobeNewswire

    Arch Therapeutics Launches Experts in Wound Care Program

    Key Opinion Leaders Share Insights on Advancing Wound CareFRAMINGHAM, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical devices, announced today that it has launched its Experts in Wound Care Program, a series of interviews with key opinion leaders dedicated to advancing wound care. The interviews will focus on important wound care topics, such as how evolving best

  • GlobeNewswire

    Arch Therapeutics Provides Corporate Update

    90-Day Report Card for Commercialization Effort FRAMINGHAM, Mass., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical devices, today provided a corporate update at the LD Micro Main Event XIV investor conference in Los Angeles, CA. The presentation slides will be publicly available through the SEC website as an attachment to the Form 8-K filed in connection with this press